Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Sarcoma × Dexrazoxane × Clear all

Phase

Status

Sponsor Class

OTHER 4 NETWORK 3 NIH 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 1 Extravasation 1 Anthracycline Extravasation 1

Interventions

Doxorubicin 30 Gemcitabine 11 pembrolizumab 10 pazopanib 8 Trabectedin 8 Irinotecan 8 eribulin 7 olaratumab 6 Cyclophosphamide 6 Injections 5 Docetaxel 5 ridaforolimus 4 anlotinib 4 Nivolumab 4 Ifosfamide 4 Bevacizumab 4 tazemetostat 3 belinostat 3 Temozolomide 3 TH 302 3 Paclitaxel 3 Ipilimumab 3 Fluorouracil 3 Epirubicin 3 Drug Therapy 3 DOXO-EMCH 3 Carboplatin 3 trastuzumab deruxtecan 2 toripalimab 2 tislelizumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05858710 2025-07-28

Study of DPPG2-TSL-DOX Combined With Hyperthermia in Soft Tissue Sarcoma

Thermosome GmbH

Phase 1 Completed

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡